This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research, Unstitut National De La Sante Et De La Rechereche Medicale. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 65 
1 out of 1,853 
1 out of 1 Years Active: 2010-2012
Title: Kevin Pethe: Innovator in Immunogenic Research
Introduction
Kevin Pethe, an accomplished inventor based in La Madeleine, France, has made significant contributions to immunogenic research, particularly in the field of mycobacterial infections. With two patents to his name, he has demonstrated his capabilities and creativity as an inventor.
Latest Patents
Kevin Pethe's latest patents focus on the development of a methylated heparin-binding hemagglutinin recombinant mycobacterial antigen. This invention covers a methylated immunogenic recombinant peptide sequence that incorporates mycobacterial heparin-binding hemagglutinin. It involves both chemical and enzymatic methods for preparation, where the sequence is first produced in a non-methylated recombinant form and then methylated through post-translational modification. Additionally, the patent details recombinant tools, vectors, and host cells that facilitate the enzymatic methylation process of recombinant HBHA. The final outcome of this ingenuity is immunogenic compositions that include methylated, native, or recombinant HBHA, which are valuable for creating vaccines against mycobacterial infections.
Career Highlights
Throughout his career, Kevin has made strides by working with reputable organizations. Notable among these are the Institut Pasteur de Lille and the National Institute of Health and Medical Research (INSERM), where he has honed his research skills and contributed to important projects in health and medical fields.
Collaborations
During his career, Kevin Pethe has collaborated with prominent colleagues, including Franco Menozzi and Camille Locht. These partnerships have further enriched his research journey and broadened the impact of his innovations in the scientific community.
Conclusion
Kevin Pethe's innovative approach to tackling mycobacterial infections through his patented inventions showcases the vital role of inventors in advancing medical research. With his contributions to immunogenic compositions and recombinant technologies, he continues to pave the way for future developments in vaccine formulation and infectious disease management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile